Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

May 31, 2012

MERCK SHARP & DOHME CORP. v. SANDOZ INC.

Track this case

Case Number:

3:12-cv-03289

Court:

New Jersey

Nature of Suit:

Patent

Judge:

Peter G. Sheridan

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. August 20, 2015

    Merck Wins Patent Dispute Over Cancer Treatment Drug

    Following a bench trial, a New Jersey federal judge on Thursday validated Merck Sharp & Dohme Corp.'s patent for an anti-nausea drug used during chemotherapy, finding that its claims are not obvious and also determining that a proposed generic drug by Sandoz Inc. would infringe the patent.

2 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login